25 episodes

Expert insight and analysis providing information directly relevant to HIV care, through topic-focused newsletters summarizing the peer-reviewed literature and accompanying podcasts to illustrate how to apply that information in the clinic.

eHIV Review eHIV Review

    • Medicine

Expert insight and analysis providing information directly relevant to HIV care, through topic-focused newsletters summarizing the peer-reviewed literature and accompanying podcasts to illustrate how to apply that information in the clinic.

    Increasing PrEP Uptake in Women

    Increasing PrEP Uptake in Women

    In the US, among women at high risk for acquiring HIV infection, only around 2% have initiated PrEP. What are the patient, provider, and system barriers to increased PrEP uptake in this vulnerable population? What can clinicians do to overcome these barriers?



    In this issue, Dr. Rachel Scott, Scientific Director of Women's Health Research at the MedStar Health Research Institute and Assistant Professor of Obstetrics and Gynecology at the Georgetown University School of Medicine, provides some answers.

    • 17 min
    Increasing PrEP Uptake in PWID

    Increasing PrEP Uptake in PWID

    Take our post-test to claim CME credits.







    To read a companion newsletter click here.







    People who inject drugs (PWID) are at risk for HIV infection from both sexual- as well as injection-related causes. What can clinicians do to reduce the incidence of infection and improve their patients’ health? In this issue, Dr. Jessica Taylor from The Boston University School of Medicine and Boston Medical Center takes us into the clinic to explain how current evidence-based strategies can increase the uptake of HIV pre-exposure prophylaxis in this vulnerable population.

    • 25 min
    Two Drug ART? — Clinical Considerations

    Two Drug ART? — Clinical Considerations

    In her recent newsletter issue (eHIV Review V5 #1), Dr. Ethel Weld, Assistant Professor of Medicine, Pharmacology and Molecular Sciences at the Johns Hopkins School of Medicine, analyzed the current research about the potential uses of two-drug ART regimens. Join her now for a case-based discussion about how that new information can affect patient selection in the clinic.







    Take our post-test to claim CME credits.







    To read a companion newsletter click here.

    • 26 min
    “U=U” — Clinical Considerations

    “U=U” — Clinical Considerations

    Volume 4, Issue 12







    “U=U” — an Undetectable HIV viral load means Untransmittable HIV virus.  In her recent eHIV Newsletter Issue (Vol. 4; No. 11), Dr. Jill Blumenthal from the Division of Infectious Diseases and Global Public Health at the University of California San Diego analyzed the current evidence strongly supporting this concept.  In this Podcast, she discusses “U=U” from the clinical perspective, and models how it can help promote patient safety.







    Take our post-test to claim CME credits.







    To read a companion newsletter click here

    • 23 min
    Clinical Aspects of Improving ART Adherence

    Clinical Aspects of Improving ART Adherence

    Volume 4, Issue 10











    In this Issue, Dr. Joyce Jones from the Johns Hopkins University School of Medicine and Dr. Barbara Taylor from the University of Texas Health Science Center at San Antonio analyze recent publications describing evidence-based ART adherence interventions and how they can be tailored to specific situations to increase effectiveness.











    Take our post-test to claim CME credits.







    To read a companion newsletter click here

    • 26 min
    Clinical Perspective: New AEs from Newer ART

    Clinical Perspective: New AEs from Newer ART

    Volume 4, Issue 8







    While newer antiviral agents like darunavir and the integrase strand transfer inhibitor (INSTI) dolutegravir have shown great efficacy, recent postmarketing surveillance has identified important adverse effects not found in the clinical trial populations.







    In this issue, Dr. Cody Chastain from the Division of Infectious Diseases at Vanderbilt University Medical Center discusses how these new findings can impact the clinical use of these new agents.







    Take our post-test to claim CME credits.







    To read a companion newsletter click here

    • 23 min

Top Podcasts In Medicine